Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Minnesota for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Minnesota only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Minnesota (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Yevgeniy Sychev (NPI 1609166768)

Field	Value
Entity Type	Individual
Organization	Yevgeniy Sychev
Address	710 E 24th St Ste 304
City	Minneapolis
State	MN
ZIP	55404
Taxonomy	Retina Specialist (Ophthalmology) Physician
NPI Enumerated	April 11, 2011

Payer Source	Total Paid
Medicare	$1.9M
Medicaid	$0

Key Findings

This provider’s Medicare revenue is overwhelmingly driven by intravitreal anti-VEGF therapy: J0178 (aflibercept) accounts for $1.1M (56.3% of Medicare revenue) across 1.6K claims, Q5128 (ranibizumab biosimilar) contributes $312.1K (16.4%) across 1.4K claims, and J2777 (faricimab) adds $130.5K (6.8%) across 4.5K claims. The code mix and volumes indicate a practice focused on high-frequency, office-based retinal injections rather than purely surgical care.

Revenue concentration is pronounced: the top three Medicare codes together account for 79.6% of this provider’s total Medicare revenue. This heavy concentration around three drug/injection codes signals that overall Medicare performance is highly dependent on continued utilization and reimbursement of those specific injection codes.

The provider is effectively single-payer in scale: Medicare revenue totals $1.9M while there is no Medicaid billing on file. The absence of Medicaid activity means payer strategy, network positioning, and revenue sensitivity should be assessed primarily through a Medicare lens rather than dual-payer dynamics.

Competitive standing varies by code: J0178 ranks #780 of 3204 providers nationally (76th percentile), and Q5128 ranks #95 of 373 (75th percentile), both characterized as typical, unremarkable national volumes for those codes. By contrast, J2777 ranks #1601 of 2039 (21st percentile) and represents a modest national presence for faricimab relative to peers, indicating differentiated uptake across therapies.

Diagnostic and follow-up services are a strong companion line: 92134 (OCT retinal imaging) appears at 2.2K claims and $66.5K revenue and ranks in the 97th percentile as notably above typical national volume, while 92012 (intermediate established E/M) is in the 96th percentile. Those notably above-typical rankings suggest an operational model that pairs frequent imaging and visits with injection-based treatment, consistent with active chronic retinal disease management.

Surgical retinal procedures are present but limited: vitrectomy and related surgery codes (67042, 67041, 67036, 67108, 67145) appear with small claim counts and mid-to-lower national ranks, generating single-digit-thousand-dollar revenues per code. This mix implies the practice performs occasional surgical cases but is primarily an office-centric injection and imaging practice rather than a high-volume surgical retina center.

Tenure is long-established: the NPI was enumerated 2011-04-11 (~15 years ago), indicating the provider has operated under Medicare for over a decade and likely has an established referral and follow-up workflow for chronic retinal conditions. That tenure supports the billing patterns observed (high imaging and repeated injections).

From a business perspective, reliance on one high-revenue drug code (J0178 at $1.1M, 56.3%) and two injection codes that form the bulk of receipts suggests revenue sensitivity to drug reimbursement, product mix shifts, and formulary changes. Payers and network planners should note that changes affecting aflibercept or ranibizumab coverage could materially affect this provider’s Medicare revenue given the 79.6% concentration in the top three codes.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

19 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0178	Injection, aflibercept, 1 mg	1,560	$690	$1.1M
Q5128	Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg	1,450	$220	$312.1K
J2777	Injection, faricimab‑svoa, 0.1 mg	4,500	$30	$130.5K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	1,390	$90	$130.2K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	2,220	$30	$66.5K
92012	For this CPT code, an Ophthalmologist sees an established patient for an intermediate level eye examination. Generally, a patient is considered to be "established" if the same physician, or any…	820	$70	$55.2K
92014	An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group…	290	$90	$25.3K
J9035	Injection, bevacizumab, 10 mg	460	$50	$25.1K
92004	The provider performs a comprehensive level ophthalmological evaluation of a new patient and initiates a diagnostic and treatment program for one or more visits.	150	$110	$16.3K
67042	In this procedure, the provider removes vitreous humor, the gelatinous material that gives shape to the eye, using a mechanical cutting tool. He removes the internal limiting membrane of the retina…	20	$900	$16.1K

Showing 1–10 of 19

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 19 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Minnesota Distribution

Yevgeniy Sychev — 3 of 19 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Minnesota

Full comparison — all codes billed, vs. state median

19 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	10	40	580	$690	$743.4K
J2777	19	20	6,120	$30	$411.1K
Q5128	8	20	1,410	$220	$393.8K
67028	12	80	420	$90	$64.8K
67042	10	10	20	$1,300	$48K
67036	4	10	20	$1,140	$37.5K
67108	8	10	10	$1,230	$34.4K
67041	6	10	20	$1,090	$25.1K
J9035	9	40	220	$50	$16.9K
92014	115	830	100	$80	$11.9K

Showing 1–10 of 19

Related Providers

Other providers that share a Tax Identification Number (TIN) with Yevgeniy Sychev, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Vitreoretinal Surgery PLLC	MN	Ophthalmology Physician	$0	$27.8M
David Williams	MN	Retina Specialist (Ophthalmology) Physician	$5.5M	$0
David Parke	MN	Ophthalmology Physician	$4.8M	$0
Sundeep Dev	MN	Ophthalmology Physician	$4.5M	$0
John Davies	MN	Ophthalmology Physician	$3.9M	$0
Polly Quiram	MN	Ophthalmology Physician	$3.7M	$0
Geoffrey Emerson	MN	Retina Specialist (Ophthalmology) Physician	$3.3M	$0
Robert Mittra	MN	Ophthalmology Physician	$3.1M	$0
Abdhish Bhavsar	MN	Retina Specialist (Ophthalmology) Physician	$2.3M	$0
Jacob Jones	MN	Retina Specialist (Ophthalmology) Physician	$2.3M	$0

Nearby Providers

Other providers in the same ZIP code as Yevgeniy Sychev, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Nu-way House Inc	MN	Substance Abuse Rehabilitation Facility	$0	$200.8M
Childrens Health Care	MN	Children's Hospital	$0	$100M
Midwest Home Health Care, Inc.	MN	Home Health Agency	$0	$73.5M
Midwest Quality Home Care, Inc.	MN	Home Health Agency	$0	$66.7M
Regents Of The University Of Minnesota	MN	Federally Qualified Health Center (FQHC)	$0	$55.2M
Minnesota Professional Health Services,inc	MN	Home Health Agency	$0	$51.9M
Park Ave Center Inc	MN	Substance Use Disorder Rehabilitation Clinic/Center	$0	$50.8M
Minnesota Quality Care, Inc.	MN	Home Health Agency	$0	$48.4M
Direct Home Health Care, Inc.	MN	Home Health Agency	$0	$30.7M
Aaa A-z Friendly Languages Inc	MN	Interpreter	$0	$29.4M

Yevgeniy Sychev — Billing Profile & Reimbursement Data

Sign up for Yevgeniy Sychev — Billing Profile & Reimbursement Data policy alerts

Yevgeniy Sychev — Billing Profile & Reimbursement Data

Sign up for Yevgeniy Sychev — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References